Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (152)
- Scheduling (national classification system) (58)
- Manufacturing (31)
- Unique Device Identification (UDI) hub (25)
- Safety monitoring and information (18)
- Compliance and enforcement (16)
- Clinical trials (13)
- Vaping hub (9)
- Legislation (8)
- Advertising (7)
- Shortages and supply disruptions (6)
- Labelling and packaging (5)
- Medicinal cannabis hub (5)
- Breast implant hub (2)
- Cosmetics (1)
- Import and export (1)
- Sunscreens (1)
Search
416 result(s) found, displaying 176 to 200
-
Committee meetingsThe 36th meeting of the Advisory Committee on Vaccines (ACV), August 2022.
-
PresentationsInformation for manufacturers, sponsors and users of the UDI data on how to access the AusUDID Sandpit
-
WebinarsInformation for manufacturers, sponsors and users of the UDI data on how to access the AusUDID Sandpit.
-
-
Committee meetingsThe 35th meeting of the Advisory Committee on Vaccines (ACV), August 2022.
-
WebinarsInformation for manufacturers, sponsors and users of UDI data on how to access the AusUDID Sandpit.
-
PresentationsTo raise awareness and engage with potential website users about the TGA website redevelopment and release.
-
Committee meetingsThe 34th meeting of the Advisory Committee on Vaccines (ACV), July 2022.
-
PresentationsInformation for manufacturers, sponsors and users of UDI data on how to access the AusUDID Sandpit.
-
Committee meetingsThe 31st joint meeting of the Advisory Committees on Medicines Scheduling and Chemicals Scheduling (Joint ACMS-ACCS #31), June 2022.
-
Committee meetingsThe 38th meeting of the Advisory Committee on Medicines Scheduling (ACMS #38), June 2022.
-
Committee meetingsThe 34th meeting of the Advisory Committee on Chemicals Scheduling (ACCS #34), June 2022.
-
-
PresentationsSignificant safety issue reporting - Changes to the Pharmacovigilance guidelines for sponsors.
-
PresentationsImproving healthcare with data collected from medicine and vaccine adverse event reporting.
-
PresentationsA presentation on current activities, collaborations, and performance of the Prescription Medicine Authorisation Branch.
-
PresentationsPost Market Surveillance - Considerations for medical device sponsors.
-
PresentationsThe increasing availability of Real World Evidence presents opportunities to improve treatments and repurpose medicines.
-
PresentationsReal world evidence in the regulation of medical devices.
-
PresentationsTGA speaker opportunity at ARCS conference.
-
PresentationsUpdates on regulatory framework and key activities from the TGA's Medical Devices Authorisation Branch.
-
PresentationsUpdates on regulatory pathways for gene therapy products in Australia.
-
PresentationsUpdates on key activities for the TGA's Manufacturing Quality Branch.
-
PresentationsUpdates on current activities and focus areas for the Complementary and Over the Counter Medicines Branch.
-
PresentationsLessons learnt from COVID-19 to improve future vaccine development.